The Department of Health and Social Care (DH) has extended the Serious Shortage Protocols (SSPs) issued for Salazopyrin EN-Tabs 500mg.
The SSP issued for Salazopyrin EN-Tabs 500mg was previously scheduled to expire on January 22, however the end date has been further extended until March 8.
|SSP & Product||Current expiry date|
|SSP08: Salazopyrin EN-Tabs 500mg||This SSP has been varied – the revised end date for SSP08 is now March 8, 2021|
|SSP05: Fluoxetine 10mg tablets
||March 31, 2021|
|SSP07: Fluoxetine 30mg capsules||March 12, 2021|
|SSP09: Fluoxetine 40mg capsules||March 31, 2021|
|SSP10: Levothyroxine 12.5mcg tablets||March 5, 2021|
Reimbursement is for the medicine supplied in accordance with the SSP and not the originally prescribed medicine.
The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor…
- One Single Activity fee (currently £1.27)
- One SSP fee (£5.35)